Deva Holding AS | DEVA - 销售毛利

金融业

TRY

TRY 12.93B

现金及等价物

TRY 775.92M

TRY 991.13M

TRY 9.13B

TRY 6.43B

TRY 5.3B

股息收益率

0.18

TRY 820.88M

TRY 882.9M

EPS每股收益

TRY 2.92

股本和储备

TRY 5.79B

TRY 1.32B

债务利息支出

TRY 272.53M

TRY 559.97M

TRY 17.83B

TRY 583.98M

TRY 1.35B

TRY 964.87M

普通股股本

TRY 200.02M

6.55

TRY 2.32B

销售和管理费用

TRY 462.26M

贸易债权人

TRY 809.81M

应收帐款人

TRY 3.03B

	销售毛利	更改		日
Akebia Therapeutics	USD 47.28M		1.7M	2025-12
Alaunos Therapeutics	USD -1.13M		1.11M	2024-09
Avita Medical	AUD 14.31M		639K	2025-12
Deva Holding AS	TRY 1.32B		235.77M	2023-09
Dianthus Therapeutics	USD 463K		179K	2026-03
Ionis Pharmaceuticals	USD 265M		22M	2026-06
IQVIA Holdings	USD 1.44B		368M	2026-06
Moderna	USD -566M		792M	2026-03
Organon & Co	USD 847M		64M	2026-06
Revvity	USD 416.87M		29.21M	2026-06
Tectonic Therapeutic	USD 0		0	2025-03
Viatris	USD 1.57B		193.9M	2026-06
Xeris Pharmaceuticals	USD 72.55M		404K	2026-03